Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution
April 22 2008 - 8:30AM
PR Newswire (US)
MUNDELEIN, Ill., April 22 /PRNewswire/ -- Sysmex America, Inc.
today announced the successful completion of Mercy Medical Center's
(Canton, OH) beta studies for its integrated hematology and A1C
automation solution. This first-of-kind solution, which combines
the Sysmex HST-N hematology automation platform and the Bio-Rad
Laboratories, Inc. VARIANT(TM) II TURBO Link, enables on-demand,
automated diabetes testing in a random access setting. "This
integrated testing solution, now fully on-line at Mercy, also
utilizes automated decision logic rules software, Sysmex MOLIS
WAM(TM), to maximize efficiencies in the area of data and sample
management and labor utilization," said Barbara Carter, Coordinator
Automated/Core Laboratory, Mercy Medical Center. Mercy Medical
Center's early adoption of the integrated hematology and A1C
Testing Solution aligns with the hospital's impressive list of
world, national, state and Stark county's "firsts." The hospital is
jointly owned and operated by the Sisters of Charity Health System
and University Hospitals Health System. This integrated testing
Solution will be available to hospitals across the nation beginning
the end of April 2008. "As an early adopter of the automated A1C
Testing Solution, we are providing superior diabetes testing
services that positively impact the quality and timeliness of the
acute care and management of diabetic patients. With diabetes
affecting over 20 million children and adults in the United States,
coupled with the nation's obesity epidemic, we saw the need to
create a laboratory infrastructure for the future," said Mary Ann
Burich-Boccia, Administrative Director, Laboratory, Mercy Medical
Center. "By automating and consolidating our high volume hematology
and diabetes testing, we have dramatically improved our operational
efficiency while reducing costs and errors. And, with seventy-five
percent of our samples no longer needing technologist-touch, we are
freeing our technologists for more critical tasks such as abnormal
patient result review," she added. Mercy Medical Center's
integrated testing solution includes the Sysmex HST-302 automated
platform -- two XE-Series automated hematology analyzers, one
SP-1000i automated slide maker and stainer, MOLIS WAM, one TS-500
Tube Sorter/archiver, Return Line and the Bio-Rad VARIANT II TURBO
Link A1C testing system. "Our A1C method uses HPLC technology, the
industry's gold standard for A1C testing. In addition to diabetes
monitoring, our method detects some common hemoglobin
abnormalities. This clinical information can be forwarded to the
physician, adding valuable patient information," said Scott Joksch,
Senior Product Manager at Bio-Rad. "In addition to enhancing its
diabetic testing services, Mercy Medical Center's foresight has
enabled the automation of testing and data management of 90% of
tests performed on EDTA samples and automated sample management of
virtually 100% of all EDTA samples (i.e. CBC, Diff, Retic, ESR and
other esoteric tests)," said Nilam Patel, Sr. Product Manager,
Automation Solutions, Sysmex America, Inc. "This Lavender Top
Management(TM) solution by Sysmex offers clinical laboratories
quality results, superior instrument and automation performance
(uptime) and improved productivity, turn around times and labor
utilization," added Patel. About HbA1c The hemoglobin A1c (A1C)
blood test, which measures the amount of glucose attached to the
hemoglobin in the red blood cell, is an estimate of a patient's
blood glucose control during the previous three to four months.
Diabetes is a chronic condition that can increase a patient's risk
for developing serious complications including heart disease and
stroke, high blood pressure, blindness, kidney and nervous system
diseases. Proper diabetes management can delay or even prevent the
onset of complications, allowing patients to live healthier, more
productive lives. About Mercy Medical Center Mercy Medical Center,
a nonprofit corporation of the Sisters of Charity Health System and
University Hospitals Health System, operates a 476-bed hospital
serving Stark, Carroll, Wayne, Holmes and Tuscarawas Counties and
parts of Southeastern Ohio. It has 550 physicians on its Medical
Staff and employs 2,500 people. Mercy operates outpatient health
centers in Carrollton, Jackson Township, Lake Township, Louisville
and North Canton. A Catholic hospital, Mercy Medical Center,
upholds the mission and philosophy of the Sisters of Charity of St.
Augustine and continues to be responsive to the needs of the
community, including the provision of care to all, regardless of
their ability to pay. For more information, see
http://www.cantonmercy.com/. About Bio-Rad Bio-Rad Laboratories,
Inc. (Amex: BIO; BIOb) has remained at the center of scientific
discovery for more than 50 years manufacturing and distributing a
broad range of products for the life science research and clinical
diagnostic markets. The company is renowned worldwide among
hospitals, universities, major research institutions, as well as
biotechnology and pharmaceutical companies for its commitment to
quality and customer service. Founded in 1952, Bio-Rad is
headquartered in Hercules, California, and serves more than 85,000
research and industry customers worldwide through its global
network of operations. The company employs approximately 6,300
people globally and had revenues approaching $1.5 billion in 2007.
For more information, visit http://www.bio-rad.com/. About Sysmex
America, Inc. Sysmex America, Inc., the U.S. headquarters of Sysmex
Corporation (Kobe, Japan), is a world leader in clinical laboratory
systemization and solutions, including clinical diagnostics,
automation and information systems. Serving customers for over 40
years, Sysmex focuses on extending the boundaries of diagnostic
science while providing the management information tools that make
a real difference in clinical and operational results for people
worldwide. For more information about Sysmex, please visit
http://www.sysmex.com/usa. DATASOURCE: Sysmex America, Inc.
CONTACT: Tonua Fedusenko of TJS Communications, Inc.,
+1-570-384-0450, cell, +1-302-893-3948, , for Sysmex America, Inc.
Web site: http://www.sysmex.com/usa http://www.bio-rad.com/
http://www.cantonmercy.com/
Copyright